Find and Pitch Jounalists, Get Your Story Covered

Tags: Coya Therapeutics Dr. Reddy's Laboratories COYA 302 Investigational Combination Therapy Amyotrophic Lateral Sclerosis

	Profile	Recent Articles on Subject
1	Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile educationpolitics	How AZ and Amgen’s Tezspire respiratory data ups the ‘level of ambition’ in immunology - 8 days ago How Astellas juggles the moving parts of cancer precision medicine development - 4 months ago Two former Alexion leaders fight through layoffs and a tough market to maintain a rare disease biotech - 5 months ago Their Alzheimer’s treatment worked — but shares fell anyway - 7 months ago 23andMe inches closes to cancer immunotherapy, guided by its genetic database - 8 months ago A new biotech tackling IBD joins a race against Lilly and Gilead for a promising pill - 9 months ago In the rapidly shrinking COVID market, this company still sees opportunity - 9 months ago The head of AstraZeneca’s new digital health spinoff on how the pharma is leveraging tech - over 1 year ago A biotech tackles drug discovery with transcription factor know-how - over 1 year ago
2	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Biotechs emerging from stealth take aim at pharma’s prime targets - 11 days ago After scoring a first for an off-the-shelf T cell therapy, can Atara maintain momentum? - 6 months ago Amylyx’s CEOs on their ALS setback and quest to revamp the pipeline - 9 months ago Behind a big-name rare disease biotech, an exec draws from personal experience - about 1 year ago Astellas’ science chief on the leap into new technologies - about 1 year ago Five years after closing the Shire deal, Takeda is ready to harvest from its latest reinvention - about 1 year ago Red Jacket: Helen Sabzevari, an immunotherapy pioneer - over 1 year ago
3	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Vertex Pharma Challenger Sionna Secures $191M in IPO Cash for Cystic Fibrosis Pipeline - about 2 months ago Galapagos Keeps Focus on Cancer Cell Therapy, Spins Out Rest of Biz Into NewCo Backed by €2.4B - 3 months ago Roche Expands Its Scope in Allogeneic Cell Therapy With $1B Poseida Therapeutics Acquisition - 4 months ago Kura Oncology Gets $330M to Kick Off Global Leukemia Drug Pact With Kyowa Kirin - 4 months ago Path Forward for Cancer Biotech G1 Therapeutics Is $405M Acquisition by Pharmacosmos - 8 months ago J.P. Morgan Leads $100M Financing for Startup’s R&D of Covalent Biologic Drugs for Cancer - 11 months ago Another ADC Developer Lands a Mega Round of Financing for Cancer Clinical Trials - 12 months ago AstraZeneca’s Rare Disease Pipeline Notches Another FDA Approval - about 1 year ago
4	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	The biotech news stories we’re keeping an eye on - 3 months ago Versant enters obesity with new startup - 4 months ago The biotech news roundup to start your week - 5 months ago The biotech news you need to read today - 5 months ago STAT+: Potential competition for RSV prophylactic Beyfortus - 6 months ago New data on liquid biopsy for colorectal cancer detection still underwhelms - about 1 year ago Novartis reportedly decides to pass on Cytokinetics - about 1 year ago Novartis is building a new radioligand plant in China - over 1 year ago The first vaccine for the increasingly prevalent chikungunya virus is here - over 1 year ago Johnson & Johnson antiviral pill for dengue shows early efficacy - over 1 year ago
5	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Merck is broadening its pipeline as Keytruda’s patent cliff looms - 3 months ago In a Duchenne market beset by problems, Capricor data marks a bright spot - 8 months ago Kyverna follows oncology’s CAR-T cell playbook for an ultra-rare autoimmune disorder - 9 months ago Execs from Bayer, Kite and Orca sound off on their launch strategies for cell and gene therapies - 11 months ago
6	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	AstraZeneca falls on reports of Chinese probe - 5 months ago
7	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: Novartis, Seagen veteran David Epstein is back, leading a new cancer startup - 5 months ago STAT+: AstraZeneca picks up rare disease-focused Amolyt Pharma in $1 billion deal - about 1 year ago STAT+: Roche to acquire obesity-focused Carmot Therapeutics for $2.7 billion - over 1 year ago
8	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about ballooning 340B drug sales, Catalent reassuring customers, and more - 6 months ago STAT+: Pharmalittle: We’re reading about Amgen suing Colorado over drug price caps, abortion pills, and more - about 1 year ago STAT+: Pharmalittle: Weight loss drugs are being paired with bariatric surgery; Carl Icahn plans to oust Illumina directors - over 1 year ago STAT+: Pharmalittle: Woodcock to retire from the FDA; Acrotech urged to speed up confirmatory study of cancer drugs - over 1 year ago STAT+: Pharmalittle: Wegovy cuts heart attack risk in milestone trial; AstraZeneca prioritizes U.S. for RSV drug amid surge - over 1 year ago STAT+: Pharmalittle: Roche buys Roivant bowel disease drug for $7.1 billion; AstraZeneca CEO calls report of imminent retirement ‘fake news’ - over 1 year ago
9	https://www.facebook.com/ichiro51 GeekWire Tech news and analysis. Seattle, Washington technologystartupsnews	Seattle startup Oisín Biotechnologies raises $15M to develop therapies for age-related diseases - 8 months ago AstraZeneca will pay up to $1.1B to acquire Icosavax, a Univ. of Washington biotech spinout - over 1 year ago
10	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Cardiovascular startup raises $260 million led by ex-Moderna execs’ new VC fund - 9 months ago STAT+: Investors funnel $275 million into Paragon Therapeutics spinout - about 1 year ago STAT+: Biotech FogPharma raises $145 million in anticipation of more clinical trials, pharma partnerships - about 1 year ago STAT+: Biotech launches with $135 million for Vertex-competing pain medicine - about 1 year ago STAT+: A Q&A with Vertex founder Joshua Boger on Casgevy, the biotech industry, and Elon Musk - over 1 year ago STAT+: Biotech incubator Curie.Bio graduates its first startup - over 1 year ago STAT+: Startup launches with $245 million for twice yearly asthma treatment - over 1 year ago

Journalists covering Coya Therapeutics